Methods and apparatus for detecting the rejection of transplanted tissue

• US 6,201,989 B1
• Filed: 03/12/1998
• Issued: 03/13/2001
• Est. Priority Date: 03/13/1997
• Status: Expired due to Fees

• Current Assignee: Biomax Technologies Pte., Ltd.
• Original Assignee: Biomax Technologies Pte., Ltd.
• Inventors: Zeng, Haishan, McManus, Bruce M., Whitehead, Peter D., Thompson, Christopher R., MacKinnon, Nicholas B., MacAulay, Calum E.
• Primary Examiner(s): Casler, Brian L.
• Application Number:
  US09/041,861
• Time in Patent Office: 1,097 Days
• Field of Search: 600/473, 600/476, 600/477, 600/478, 600/310, 356/432, 250/458.1, 250/461.1, 250/461.2, 250/483.1, 250/484.2, 250/484.4, 250/492.1, 250/358.1
• US Class Current: 600/476
• CPC Class Codes: A61B 10/06 Biopsy forceps , e.g. with cup-shaped jaws
• CPC Class Codes: A61B 2017/2934 arcuate shaped guiding means
• CPC Class Codes: A61B 2090/3614 using optical fibre
• CPC Class Codes: A61B 2090/373 using light, e.g. by using optical scanners
• CPC Class Codes: A61B 5/0066 Optical coherence imaging
• CPC Class Codes: A61B 5/0071 by measuring fluorescence emission
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0084 for introduction into the body, e.g. by catheters A61B5/1459 takes precedence
• CPC Class Codes: A61B 5/0086 using infrared radiation
• CPC Class Codes: A61B 5/413 Monitoring transplanted tissue or organ, e.g. for possible rejection reactions after a transplant
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/6848 Needles
• CPC Class Codes: A61B 5/7285 for synchronising or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal A61B6/5205, A61B6/541, A61B8/5207, A61B8/543 take precedence

Abstract

Methods and apparatus for detecting the possible rejection of a transplanted tissue by a host. The transplanted tissue is subjected to illumination with light to induce fluorescence. The light can be ultraviolet light, visible light or infrared light, which can be used alone or in any combination, which means one, two or three forms of light may be used together. The induced fluorescence is collected and analyzed, then compared with fluorescence that is obtained using the same procedure for a known, healthy tissue that is the same type of tissue as the transplanted tissue. Also provided are methods and apparatus related to the determination of probe orientation and the need for biopsy.

Claims

1. A method for determining whether a transplanted tissue comprises one or more characteristics indicative of rejection by a host, the method comprising:

a) illuminating the transplanted tissue under conditions suitable to cause the transplanted tissue to fluoresce;

b) collecting the fluorescence to provide a transplant fluorescence signature; and

c) comparing the transplant fluorescence signature with a known fluorescence signature representative of a same type of tissue as the transplanted tissue, and therefrom determining whether the transplanted tissue exhibits one or more characteristics indicative of rejection,

wherein the method is implemented using a catheter or endoscope that comprises at least one illumination light guide that conducts light to the transplanted tissue to illuminate the transplanted tissue and at least one collection light guide that collects fluorescence from the transplanted tissue, and wherein the method further comprises collecting a plurality of transplant fluorescence signatures, wherein at least two of the plurality of transplant fluorescence signatures comprise a significant fluorescence contribution from a plurality of selected different depths of the transplanted tissue to provide at least two different fluorescence signatures.

2. The method of claim 1 wherein the catheter or endoscope comprises at least a first collection light guide and a second collection light guide each of which is spaced a different distance from its associated illumination light guide, and wherein the collection of the at least two different fluorescence signatures comprises collecting light using each of the first collection light guide and the second collection guide during the collecting steps.

3. The method of claim 2 wherein the illumination light guide associated with the first collection light guide and the second collection light guide is a single light guide.

4. The method of claim 1 wherein the step of comparing comprises comparing the wavelength of maximum intensity of the transplant fluorescence signature with the healthy fluorescence signature.

18. The method of any one of claims 1 to 8 or 16 to 4 wherein the transplanted tissue is illuminated and the fluorescence is collected in vivo.

19. The method of any one of claims 1-4 wherein the host is a human.

20. The method of any one of claims 1-4 wherein at least one step of the method is computer implemented.

5. A method for determining whether a transplanted tissue comprises one or more characteristics indicative of rejection by a host, the method comprising:

a) illuminating the transplanted tissue under conditions suitable to cause the transplanted tissue to fluoresce;

b) collecting the fluorescence to provide a transplant fluorescence signature; and

c) comparing the transplant fluorescence signature with a known fluorescence signature representative of the same type of tissue as the transplanted tissue, and therefrom determining whether the transplanted tissue exhibits one or more characteristics indicative of rejection, wherein the transplanted tissue is illuminated with light that does not comprise UV light.

6. A method for determining whether a transplanted tissue comprises one or more characteristics indicative of rejection by a host, the method comprising:

a) illuminating the transplanted tissue under conditions suitable to cause the transplanted tissue to fluoresce;

b) collecting the fluorescence to provide a transplant fluorescence signature; and

c) comparing the transplant fluorescence signature with a known fluorescence signature representative of the same type of tissue as the transplanted tissue, and therefrom determining whether the transplanted tissue exhibits one or more characteristics indicative of rejection,

wherein the transplanted tissue is illuminated with light that consists essentially of blue light.

7. A method for determining whether a transplanted tissue comprises one or more characteristics indicative of rejection by a host, the method comprising:

a) illuminating the transplanted tissue under conditions suitable to cause the transplanted tissue to fluoresce;

b) collecting the fluorescence to provide a transplant fluorescence signature; and

c) comparing the transplant fluorescence signature with a known fluorescence signature representative of the same type of tissue as the transplanted tissue, and therefrom determining whether the transplanted tissue exhibits one or more characteristics indicative of rejection,

wherein the transplanted tissue is illuminated with light that consists essentially of a wavelength of about 442 nm.

8. A method for determining whether a transplanted tissue comprises one or more characteristics indicative of rejection by a host, the method comprising:

a) illuminating the transplanted tissue under conditions suitable to cause the transplanted tissue to fluoresce;

b) collecting the fluorescence to provide a transplant fluorescence signature; and

c) comparing the transplant fluorescence signature with a known fluorescence signature representative of the same type of tissue as the transplanted tissue, and therefrom determining whether the transplanted tissue exhibits one or more characteristics indicative of rejection,

wherein the step of illuminating comprises illuminating light from an illumination light guide, and the step of collecting comprises collecting the fluorescence in a collection light guide.

9. A method for determining whether a transplanted tissue comprises one or more characteristics indicative of rejection by a host, the method comprising:

a) illuminating the transplanted tissue under conditions suitable to cause the transplanted tissue to fluoresce;

b) collecting the fluorescence to provide a transplant fluorescence signature; and

c) comparing the transplant fluorescence signature with a known fluorescence signature representative of the same type of tissue as the transplanted tissue, and therefrom determining whether the transplanted tissue exhibits one or more characteristics indicative of rejection,

wherein the steps of illuminating and collecting are performed in vivo during a single diastole of a heartbeat of the host.

10. The method of claim 9 wherein the steps of illuminating and collecting during a single diastole are initiated using one or more signals of an electrocardiogram.

11. The method of claim 9 wherein the steps of illuminating and collecting during a single diastole are initiated using a blood pressure pulse of the host.

12. The method of claim 11 wherein the blood pressure pulse is measured using a blood pressure monitor located externally to the host.

13. The method of claim 12 wherein the wavelength bands are measured by broad band optical detectors.

14. The method of claim 11 wherein the blood pressure pulse is measured by a pulse oximeter.

15. The method of claim 14 wherein the method further comprises selecting a specific spectral region using an optical band pass filter.

16. A method for determining whether a transplanted tissue comprises one or more characteristics indicative of rejection by a host, the method comprising:

a) illuminating the transplanted tissue under conditions suitable to cause the transplanted tissue to fluoresce;

b) collecting the fluorescence to provide a transplant fluorescence signature; and

c) comparing the transplant fluorescence signature with a known fluorescence signature representative of the same type of tissue as the transplanted tissue, and therefrom determining whether the transplanted tissue exhibits one or more characteristics indicative of rejection,

wherein the step of comparing comprises comparing a full width at half maximum (FWHM) of the transplant fluorescence signature with the healthy fluorescence signature.

17. A method for determining whether a transplanted tissue comprises one or more characteristics indicative of rejection by a host, the method comprising:

a) illuminating the transplanted tissue under conditions suitable to cause the transplanted tissue to fluoresce;

b) collecting the fluorescence to provide a transplant fluorescence signature; and

c) comparing the transplant fluorescence signature with a known fluorescence signature representative of the same type of tissue as the transplanted tissue, and therefrom determining whether the transplanted tissue exhibits one or more characteristics indicative of rejection,

wherein the step of comparing comprises comparing a ratio of the integrated intensity of two or more wavelength bands of the transplant fluorescence signature with the healthy fluorescence signature.